本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

BioNTech SE

112.70
-2.0700-1.80%
成交量:37.65万
成交额:4,228.08万
市值:270.19亿
市盈率:-52.06
高:113.24
开:112.26
低:111.30
收:114.77
数据加载中...
2024/03/20

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/21

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/02/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/09/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/06/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/03/27

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/22

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/13

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments